Search research articles
Contact Us
Filters
Showing results (91-100 of 260) with videos related to
Page
of 26
Sort By:
Transplantation and Cellular Therapy
|
April 23, 2023
Health-Related Quality of Life in Double Umbilical Cord Blood versus Haploidentical Marrow Transplantation: A Quality of Life Analysis Report of BMT CTN 1101
Najla El Jurdi, Michael J Martens, Claudio G Brunstein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 21, 2007
Mapping MHC-resident transplantation determinants
Mari Malkki, Ted A Gooley, Mary M Horowitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 22, 2018
Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant
Christopher Strouse, Ying Zhang, Mei-Jie Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2012
Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation
Marcelo C Pasquini, Steven Devine, Adam Mendizabal, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 29, 2013
Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma
Robert Frank Cornell, Parameswaran Hari, Mei-Jie Zhang, et al.
Blood Advances
|
February 7, 2020
Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial
Jennifer M Knight, J Douglas Rizzo, Parameswaran Hari, et al.
Blood
|
May 10, 2005
Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study
Jean-Yves Cahn, John P Klein, Stephanie J Lee, et al.
Blood
|
April 6, 2011
Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies
Robert J Soiffer, Jennifer Lerademacher, Vincent Ho, et al.
The New England Journal of Medicine
|
October 30, 2014
One-unit versus two-unit cord-blood transplantation for hematologic cancers
John E Wagner, Mary Eapen, Shelly Carter, et al.
JAMA Oncology
|
December 13, 2019
Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study
Ehab Atallah, Brent Logan, Min Chen, et al.
Page
of 26
Search research articles
Search
Showing results (91-100 of 260) with videos related to
Sort By:
Page
of 26
Transplantation and Cellular Therapy
|
April 23, 2023
Health-Related Quality of Life in Double Umbilical Cord Blood versus Haploidentical Marrow Transplantation: A Quality of Life Analysis Report of BMT CTN 1101
Najla El Jurdi, Michael J Martens, Claudio G Brunstein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 21, 2007
Mapping MHC-resident transplantation determinants
Mari Malkki, Ted A Gooley, Mary M Horowitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 22, 2018
Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant
Christopher Strouse, Ying Zhang, Mei-Jie Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2012
Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation
Marcelo C Pasquini, Steven Devine, Adam Mendizabal, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 29, 2013
Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma
Robert Frank Cornell, Parameswaran Hari, Mei-Jie Zhang, et al.
Blood Advances
|
February 7, 2020
Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial
Jennifer M Knight, J Douglas Rizzo, Parameswaran Hari, et al.
Blood
|
May 10, 2005
Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study
Jean-Yves Cahn, John P Klein, Stephanie J Lee, et al.
Blood
|
April 6, 2011
Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies
Robert J Soiffer, Jennifer Lerademacher, Vincent Ho, et al.
The New England Journal of Medicine
|
October 30, 2014
One-unit versus two-unit cord-blood transplantation for hematologic cancers
John E Wagner, Mary Eapen, Shelly Carter, et al.
JAMA Oncology
|
December 13, 2019
Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study
Ehab Atallah, Brent Logan, Min Chen, et al.
Page
of 26